Bard Says Vein Filter Risks Reasonable As Trial Wraps

By Cara Salvatore (October 3, 2018, 11:57 PM EDT) -- C.R. Bard Inc. closed out the third bellwether trial in its vein filter litigation on Wednesday with an argument that the implant's occasional drifting and breakage were reasonable risks, while lawyers for the patient suing the device maker told a Phoenix federal jury that the company should have halted sales instead of slowly introducing a sturdier design....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!